0001628280-19-014433.txt : 20191121 0001628280-19-014433.hdr.sgml : 20191121 20191121183216 ACCESSION NUMBER: 0001628280-19-014433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191119 FILED AS OF DATE: 20191121 DATE AS OF CHANGE: 20191121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talasaz AmirAli CENTRAL INDEX KEY: 0001753159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 191238293 MAIL ADDRESS: STREET 1: 18 ISABELLA AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_157437912073490.xml FORM 4 X0306 4 2019-11-19 0 0001576280 Guardant Health, Inc. GH 0001753159 Talasaz AmirAli 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chairman, President and COO COMMON STOCK 2019-11-20 4 S 0 33 78.54 D 7906 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-11-20 4 S 0 910 79.12 D 6996 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-11-20 4 S 0 367 79.97 D 6629 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 737800 I Shares held by Talasaz Investments, L.P. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.78 to $78.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.78 to $79.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.78 to $80.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This Form 4 is the second of two filed. /s/ Michael Wiley, as Attorney-in-Fact for AmirAli Talasaz 2019-11-21